Event & Product News

Pharmapack 2019: Solutions for digital and electronic drug delivery products with micro rotary piston pumps

Düsseldorf/Paris, December 04, 2018 – On February 6 and 7, Gerresheimer will be showcasing its products at the Pharmapack in Paris with its new subsidiary Sensile Medical AG for the first time. In July of this year, Gerresheimer acquired Sensile Medical, expanding its business model to become an original equipment manufacturer (OEM) for drug delivery platforms with digital and electronic capabilities. The company works closely with pharmaceutical and biotech companies to develop devices to deliver liquid drugs. At Pharmapack in Paris, Porte de Versailles, Sensile Medical will be at Stand A94 and Gerresheimer at Stand B62.

“Sensile Medical specializes in the development of key technologies for the patient-oriented delivery of liquid drugs,” says Sandra de Haan, Chief Business Officer at Sensile. Sensile Medical’s leading position in micro pump technology combined with drug delivery devices featuring electronic and connected capabilities for medical applications is progressing to market readiness in specific customer projects with pharma companies. The company is involved with pharma companies in the early stages of drug and therapy development. Sensile Medical is to become the Development Division, covering the field of development devices for the entire Gerresheimer Group. It is already working very successfully on projects with customers to develop devices for diabetics and patients with heart disease and in other treatment areas such as Parkinson’s disease.

The micro rotary piston pump – small and precise in dosage

Sensile Medical AG has developed a new kind of patented micro pump, which is the key component of all product platforms. SenseCore is small and very precise in dosage. Consisting of only two plastic parts, it can be produced at a low cost. Thanks to its high degree of flexibility, it is compatible with a variety of drugs.

Wearable micro pump certified to EU standards for Parkinson’s treatment

A wearable micro pump of this type designed specifically for the treatment of Parkinson’s received the EU certificate only recently. A European pharmaceutical company has obtained the CE declaration and will now launch the product on the market. This is makes it the first micropump by Gerresheimer’s subsidiary Sensile Medical to be used commercially. The micro pump is used in advanced Parkinson’s treatment. 

About Sensile Medical AG

Founded in 2004, Sensile Medical AG is a Swiss medical technology company that has been a subsidiary of Gerresheimer AG since 2018. Working with pharmaceutical companies, it develops devices to deliver liquid drugs for the best level of treatment. The patented SenseCore technology forms the heart of the system. The micro pump is extremely precise in dosage. The products are characterized by modularity and flexibility. Sensile Medical has a workforce of some 120 employees at its headquarters in Olten, Switzerland. www.sensile-medical.com

About Gerresheimer

Gerresheimer is a leading global partner to the pharma and healthcare industry. With specialty glass and plastic products, the Company contributes to health and well-being. Gerresheimer operates worldwide and its approximately 10,000 employees manufacture products in local markets, close to its customers. With our plants in Europe, North America, South America, and Asia, we generate revenues of approximately EUR 1.4 billion. The comprehensive product portfolio includes pharmaceutical packaging and products for the safe, simple administration of medicines: insulin pens, inhalers, micro pumps, prefillable syringes, injection vials, ampoules, bottles, and containers for liquid and solid medicines with closure and safety systems as well as packaging for the cosmetics industry.

Contact